Mr  Satyen Sanghavi  The Chief Scientific Officer of one of the leading stem cell therapy companies RMS said   Stem Cell therapies and banking have had the perception of being expensive and only affordable for the elite and the privileged  However this is no longer true for umbilical cord banking  Stem cell banking is now available at low prices such as 6 rupees a day  Several companies like RMS are offering EMI facilities making it one of the most affordable bi insurance for one s child which can be used to treat a wide range of debilitating clinical conditions
 
The  concept  of  stem  cell  banking  has  been  around  in  India  for  some  time  now  however  there still exists a large group of people who remain unaware about the concept of stem cell banking and its benefits 
 
Out of the 30 000 children born every day in India  almost 30 are diagnosed with neonatal disorders  Add this statistic to the  2 million children 5 years of age  that suffer from innumerable other diseases  several of which can be treated via stem cell therapy  and it is hard to overlook the fact that despite increased life expectancy due to superior medical technology  India lags behind in the clinical application of such medical advancements 
 
Regenerative medical research has established the significance of stem cells in transplantation based therapies and their viability as a medical therapeutic option for several blood and immune related disorders and various others  Given their potency and efficacy in the medical field  one can only wonder why the buzz concerning stem cells is seemingly low in a country like India that houses the second largest population in the world  Part of this could be attributed to the lack of awareness among both medical and non medical personnel alike and on the occasion of WORLD STEM CELL AWARENESS DAY  it is only fitting that efforts are made to increase consciousness about what is now the future of clinical medicine 
 
The concept of stem cell banking has been around in India for over 5 years now  With time  an increasing number of people are beginning to seek more information on stem cell therapies as an alternative to traditionally accepted medical treatment options  Major players in the Indian stem cell market are into cord blood banking and Adult stem cell therapy  Adult stem cell therapy includes autologous cell therapy for cartilage regeneration or ACI  and Autologous Bone Implantation  ABI   Although there are innumerable other potential uses of stem cells  most are in the clinical trial phase showing promising results  while the above mentioned players have already established themselves as scientifically proven and medically accepted therapies 
 
With over 6 cord blood banks established in India  expectant parents are slowly displaying the increasing curiosity about cord blood stem cells and their life saving potential   More and more parents are now seeking information about the concept and its future uses for the expectant child and family at large  The gynecologist s approach towards pregnancy is slowly changing and it is time that medical personnel stay up to date on the advancements in regenerative medicine   says Dr  Reshma Pai  an accomplished Gynecologist from Mumbai
 
Dr  Nandita Palsethkar says  By saving the cord blood of our children  we provide them access to his or her own genetically unique stem cells which he or she may use to find cure from a number of diseases in the future which secures the health of a child for years to come
Stem cell therapies have also caused quite a stir in the orthopedic sector  With increased incidences of osteoarthritis  and joint injuries  cell therapies such as ACI and ABI  CHONDRON   OSSRON  are becoming an increasingly popular treatment choice among both surgeons and patients with minimal invasion  decreased side effects  and high safety and efficacy  autologous cell therapies are steadily outnumbering traditional treatments  Stem Cell specialist and CSO of RMS Regrow  Dr  Satyen Sanghavi says  Long term results of our Autologous Cellular Therapies  ACI  ABI  show a high rate of success  opening the future of Adult stem cell based therapies for different indications   It is evident that India is slowly catching on to the stem cell banking trend with its giant leaps with a growth of over 300 in the last one year which gives hope to the Indian stem cell industry